Modern view on rosacea: Topical issues of epidemiology, pathogenesis and therapy. Literature review

Abstract

Rosacea is a multifactorial dermatological disease that is widespread throughout the world, initially manifested as a cosmetic defect, and in the absence of systemic and topical therapy leads to a change in the structure and functions of the facial skin.

Patients with rosacea often seek medical attention, as these aesthetic problems impair their quality of life and contribute to the development of social and psychological problems. Chronic stress is often the cause of the development of social maladaptation, which occurs because of a constant feeling of self-doubt, own inferiority, and anxiety. Anxiety and chronic depression can cause even minor manifestations of rosacea, as it is localized on the skin of the face. Dermatosis often manifests itself in women older than 30 years, under the influence of multiple trigger factors, has a chronic relapsing course.

Understanding the pathophysiology and the use of combined therapies can improve the effectiveness of therapy in patients with rosacea, achieve and prolong clinical remission, identify trigger factors and possible prevention. This explains the need to study rosacea not as an independent dermatosis, but as a sign of more significant disorders that can lead not only to social and aesthetic problems, but also affect the general health of the patient.

Keywords

rosacea / fima / etiology / pathogenesis / classification / treatment / review

References

[1] Olisova OY, Kochergin NG, Smirnova EA. Innovations in external therapy of rosacea. Russ J Skin Venereal Dis. 2017;20(5):270–274. (In Russ). doi: 10.18821/1560-9588-2017-20-5-270-274

[2] Олисова О.Ю., Кочергин Н.Г., Смирнова Е.А. Инновации в наружной терапии розацеа // Российский журнал кожных и венерических болезней. 2017. Т. 20, № 5. С. 270–274. doi: 10.18821/1560-9588-2017-20-5-270-274

[3] Gorbakova EV, Masyukova SA, Ilyina IV, et al. Pathophysiology of inflammation and directions of therapy for rosacea. Bulletin Med Institute Continuing Education. 2022;(3):44–47. (In Russ). doi: 10.46393/27821714-2022-3-44

[4] Горбакова Е.В., Масюкова С.А., Ильина И.В., и др. Патофизиология воспаления и направления терапии при розацеа // Вестник медицинского института непрерывного образования. 2022. № 3. С. 44–47. doi: 10.46393/27821714-2022-3-44

[5] Kubanova AA, Makhakova YB. Rosacea: Prevalence, pathogenesis, features of clinical manifestations. Bulletin Dermatol Venereol. 2015;(3):36–45. (In Russ).

[6] Кубанова А.А., Махакова Ю.Б. Розацеа: распространенность, патогенез, особенности клинических проявлений // Вестник дерматологии и венерологии. 2015. № 3. С. 36–45.

[7] Evseeva AL, Ryabova VV, Koshkin SV. Clinical case of papulopustular rosacea. Bulletin Dermatol Venereol. 2021;97(3):73–79. (In Russ). doi: 10.25208/vdv1228

[8] Евсеева А.Л., Рябова В.В., Кошкин С.В. Клинический случай папулопустулезной розацеа // Вестник дерматологии и венерологии. 2021. T. 97, № 3. С. 73–79. doi: 10.25208/vdv1228

[9] Chang AL, Raber I, Xu J, et al. Assessment of the genetic basis of rosacea by genome-wide association study. J Invest Dermatol. 2015;135(6):1548–1555. doi: 10.1038/jid.2015.53

[10] Chang A.L., Raber I., Xu J., et al. Assessment of the genetic basis of rosacea by genome-wide association study // J Invest Dermatol. 2015. Vol. 135, N 6. Р. 1548–1555. doi: 10.1038/jid.2015.53

[11] Two AM, Del Rosso JQ. Kallikrein 5-mediated inflammation in rosacea: Clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefit. J Clin Aesthet Dermatol. 2014;7(1):20–25.

[12] Two A.M., Del Rosso J.Q. Kallikrein 5-mediated inflammation in rosacea: Clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefit // J Clin Aesthet Dermatol. 2014. Vol. 7, N 1. Р. 20–25.

[13] Yamasaki K, Kanada K, Macleod DT, et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol. 2011; 131(3):688–697. doi: 10.1038/ jid.2010.351

[14] Yamasaki K., Kanada K., Macleod D.T., et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes // J Invest Dermatol. 2011. Vol. 131, N 3. Р. 688–697. doi: 10.1038/ jid.2010.351

[15] Sulk M, Seeliger S, Aubert J, et al. Distribution and expression of nonneuronal transient receptor potential (TRPV) ion channels in rosacea. J Invest Dermatol. 2012;132(4):1253–1262. doi: 10.1038/jid.2011.424

[16] Sulk M., Seeliger S., Aubert J., et al. Distribution and expression of nonneuronal transient receptor potential (TRPV) ion channels in rosacea // J Invest Dermatol. 2012. Vol. 132, N 4. Р. 1253–1262. doi: 10.1038/jid.2011.424

[17] Gerber PA, Buhren BA, Steinhoff M, Homey B. Rosacea: The cytokine and chemokine network. J Investig Dermatol Symp Proc. 2011;15(1):407. doi: 10.1038/jidsymp.2011.9

[18] Gerber P.A., Buhren B.A., Steinhoff M., Homey B. Rosacea: The cytokine and chemokine network // J Investig Dermatol Symp Proc. 2011. Vol. 15, N 1. Р. 407. doi: 10.1038/jidsymp.2011.9

[19] Ryabova VV, Koshkin SV, Chermnykh TV. Rosacea. Seborrhea. Acne. Illustrated textbook for doctors. Kirov: Kirovskaya gosudarstvennaya meditsinskaya akademiya; 2011. Р. 103–106. (In Russ).

[20] Рябова В.В., Кошкин С.В., Чермных Т.В. Розацеа. Себорея. Угревая болезнь. Иллюстрированное учебное пособие для врачей. Киров: Кировская ГМА, 2011. С. 103–106.

[21] Adaskevich VP. Classical subtypes of rosacea and rare clinical forms: Features of patient management. Smolensk Medical Almanac. 2020;(4):150–151. (In Russ). doi: 10.37963/ SMA.2020.4.150

[22] Адаскевич В.П. Классические подтипы розацеа и редкие клинические формы: особенности ведения пациентов // Смоленский медицинский альманах. 2020. № 4. C. 150–151. doi: 10.37963/ SMA.2020.4.150

[23] Mikhneva EN. Treatment of rosacea. Dermatol Venereol. 2012;(4):90–95. (In Russ).

[24] Михнева Е.Н. Лечение розацеа // Дерматология и венерология. 2012. № 4. С. 90–95.

[25] Butov YS. Dermatovenerology. National leadership. Short edition. Ed. by Yu.S. Butov, Yu.K. Skripkin, O.L. Ivanov. Moscow: GEOTAR-Media; 2020. Р. 668–680. (In Russ).

[26] Бутов, Ю.С. Дерматовенерология. Национальное руководство. Краткое издание / под ред. Ю.С. Бутова, Ю.К. Скрипкина, О.Л. Иванова. Москва: ГЭОТАР-Медиа, 2020. С. 668–680.

[27] Chauhan N, Ellis DA. Rosacea: Patophyziology and management principles. Facsial Plast Surg Clin North Am. 2013;21(l):127–136. doi: 10.1016/j.fsc.2012.11.004

[28] Chauhan N., Ellis D.A. Rosacea: Patophyziology and management principles // Facsial Plast Surg Clin North Am. 2013. Vol. 21, N l. Р. 127–136. doi: 10.1016/j.fsc.2012.11.004

[29] Kubanova AA, Dubenskiy VV, Dubenskiy VlV. Basic principles of treatment of skin diseases. In: Skripkin Yu.K., Butov Yu.S., Ivanov O.L., ed. Dermatovenerology. National Leadership. Moscow: GEOTAR-Media; 2011. Р. 197–207. (In Russ).

[30] Кубанова А.А., Дубенский В.В., Дубенский Вл.В. Основные принципы лечения болезней кожи // Скрипкин Ю.К., Бутов Ю.С., Иванов О.Л., ред. Дерматовенерология. Национальное руководство. Москва: ГЭОТАР-Медиа, 2011. С. 197–207.

[31] Mimov AV. Combined use of pulsed laser radiation and ultrasound exposure in the treatment of rosacea patients. Bulletin New Med Technol. 2013;(1):1–3. (In Russ).

[32] Мимов А.В., Котенко К.В., Круглова Л.С. Комбинированное применение импульсного лазерного излучения и ультразвукового воздействия в лечении больных розацеа // Вестник новых медицинских технологий. 2013. № 1. С. 1–3.

[33] Kubanova AA, Makhakova YB. Rosacea: Diagnosis and treatment. Bulletin Dermatol Venereol. 2015;(4):27–35. (In Russ).

[34] Кубанова А.А., Махакова Ю.Б. Розацеа: диагностика и лечение // Вестник дерматологии и венерологии 2015. № 4. С. 27–35.

RIGHTS & PERMISSIONS

Aleksandrova O.A., Dubenskiy V.V., Muraveva E.S., Tenyaev M.A.